WebMirabegron is a moderate inhibitor of CYP2D6 and co-administration with desipramine and metoprolol resulted in increases in their AUC and Cmax. Appropriate monitoring and dose adjustment may be necessary, particularly for other CYP2D6 substrates with a narrow therapeutic index such as thioridazine, flecainide, and propafenone. WebMay 7, 2024 · In the United States, mirabegron and solifenacin succinate are marketed as Myrbetriq ... flecainide, and propafenone. In solifenacin succinate monotherapy studies, for the 5mg dose one serious adverse event (angioneurotic edema) was reported. For the 10mg dose, three intestinal serious adverse events were reported (one fecal impaction, one ...
Myrbetriq Interactions Checker - Drugs.com
WebThere are 223 drugs known to interact with Myrbetriq (mirabegron), along with 4 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 8 are major, 89 are moderate, and 126 are minor. Does Myrbetriq interact with my other drugs? Enter other medications to view a detailed report. ... WebMYRBETRIQ® (mirabegron extended-release tablets) is a prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage. ... (Mellaril™ and Mellaril-S™), … flight class hogwarts legacy
flecainide oral (Tambocor Oral) Drug Interactions - RxList
WebFeb 10, 2024 · Flecainide: Mirabegron may increase the serum concentration of Flecainide. Management: Monitor clinical response to flecainide closely. Dose … WebMirabegron Tablet, Extended Release 24 Hr - Uses, Side Effects, and More Common Brand(S): Myrbetriq ... Examples of affected drugs include flecainide, propafenone, … WebFeb 10, 2024 · Flecainide: Mirabegron may increase the serum concentration of Flecainide. Management: Monitor clinical response to flecainide closely. Dose adjustment may be necessary. Canadian mirabegron labeling recommends restricting the maximum adult mirabegron dose to 25 mg/day in patients receiving flecainide. chemin terroux